Name: Pyxis Oncology, Inc. (PYXS) Balance Sheet
Creator: FinSpry

Pyxis Oncology Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Pyxis Oncology, Inc. (PYXS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	19.47	9.66	179.29	274.74	8.08
Short-Term Investments	107.46	109.63	0.00	0.00	0.00
Cash & Short-Term Investments	126.93	119.30	179.29	274.74	8.08
Accounts Receivable	0.00	0.02	0.60	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	3.28	1.01	1.31	1.76	0.01
Total Current Assets	132.44	124.60	186.61	278.67	8.10
Non-Current Assets
Property, Plant & Equipment (Net)	22.14	24.81	24.77	1.24	1.94
Intangible Assets	2.60	24.31	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.11	0.11
Total Non-Current Assets	24.74	49.12	24.77	1.35	0.00
Total Assets	157.18	173.73	211.38	280.02	10.15
Current Liabilities
Accounts Payable	4.86	3.90	7.10	11.95	1.08
Short-Term Debt	2.90	0.00	0.00	0.00	0.00
Accrued Liabilities	6.75	12.62	23.45	6.33	1.88
Deferred Revenue	0.00	7.66	0.00	0.00	0.00
Other Current Liabilities	0.64	0.36	1.09	0.27	0.12
Total Current Liabilities	17.68	25.76	31.63	18.71	3.69
Non-Current Liabilities
Long-Term Debt	18.75	20.10	18.92	0.00	0.00
Deferred Tax Liabilities	0.00	2.16	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	18.75	22.26	18.92	0.00	0.00
Total Liabilities	36.43	48.02	50.56	18.71	3.85
Stockholders' Equity
Common Stock	0.06	0.05	0.03	0.03	0.00
Retained Earnings	-363.56	-286.23	-212.44	-91.72	-15.74
Accumulated Other Comprehensive Income	0.17	0.06	0.00	0.00	0.00
Additional Paid-in Capital	484.08	411.82	373.23	353.00	0.00
Shares Outstanding	59.97	44.75	34.96	32.22	0.00
Total Stockholders' Equity	120.75	125.70	160.82	261.31	6.30
Total Liabilities & Equity	157.18	173.73	211.38	280.02	0.00